Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: A multilevel model

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 10, 2012, Pages 2523-2530

  Vellinga, Akke ^a   Tansey, Sana ^b   Hanahoe, Belinda ^b   Bennett, Kathleen ^c   Murphy, Andrew W ^a   Cormican, Martin ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Antimicrobial resistance; E. coli; UTIs

Indexed keywords

CIPROFLOXACIN; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL PRACTICE; CONSULTATION; DRUG EXPOSURE; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTILEVEL ANALYSIS; NONHUMAN; PRESCRIPTION; PROBABILITY; URINALYSIS; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CIPROFLOXACIN; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM; URINARY TRACT INFECTIONS;

EID: 84866611719     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks222     Document Type: Article

References (35)

1. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ 2006; 332: 94-7.
2. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-20.
3. Steinke DT, Seaton RA, Phillips G et al. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001; 47: 781-7.
4. Donnan PT, Wei L, Steinke DT et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. BMJ 2004; 328: 1297.
5. Butler CC, Dunstan F, Heginbothom M et al. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007; 57: 785-92.
6. Hillier S, Roberts Z, Dunstan F et al. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 2007; 60: 92-9.
7. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
8. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
9. Davey P, Ferech M, Ansari F et al. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother 2008; 62: 1441-7.
10. Vellinga A, Bennett K, Murphy AWet al. Principles of multilevel analysis and its relevance to studies of antimicrobial resistance. J Antimicrob Chemother 2012; 67: 2316-22.
11. Vellinga A, Murphy AW, Hanahoe B et al. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother 2010; 65: 1514-20.
12. Vellinga A, Cormican M, Hanahoe B et al. Opt-out as an acceptable method of obtaining consent in medical research: a short report. BMC Med Res Methodol 2011; 11: 40.
13. Vellinga A, Cormican M, Hanahoe B et al. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland. BMC Fam Pract 2011; 12: 108.
14. Clinical and Laboratory Standards Institute. Subcommittee on Antimicrobial Susceptibility Testing. 2010. http://www.clsi.org/Content/NavigationMenu/Committees/Microbiology/AST/AST.htm (1 September 2010, date last accessed).
15. Ribot EM, Fair MA, Gautom R et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006; 3: 59-67.
16. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
17. Snijders T, Bosker R. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modelling. London: Sage, 1999.
18. Larsen K, Petersen JH, Budtz-Jorgensen E et al. Interpreting parameters in the logistic regression model with random effects. Biometrics 2000; 56: 909-14.
19. Merlo J, Chaix B, Ohlsson H et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006; 60: 290-7.
20. Rasbash J, Steele F, Browne WJ et al. A User's Guide to MLwiN, Version 2.0. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London, 2003.
21. Browne WJ. MCMC Estimation in MLwiN. Version 2.0. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London, 2003.
22. Rooney PJ, O'Leary MC, Loughrey AC et al. Nursing homes as a reservoir of extended-spectrum b-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-41.
23. Subramanian SV, Glymour M, Kawachi I. Identifying causal ecologic effects on health: potentials and challenges. In: Galea S, ed. Macrosocial Determinants of Population Health. New York: Springer Media, 2007; 301-31.
24. Merlo J, Ohlsson H, Lynch KF et al. Individual and collective bodies: using measures of variance and association in contextual epidemiology. J Epidemiol Community Health 2009; 63: 1043-8.
25. Moineddin R, Matheson FI, Glazier RH. A simulation study of sample size for multilevel logistic regression models. BMC Med Res Methodol 2007; 7: 34.
26. Theall KP, Scribner R, Broyles S et al. Impact of small group size on neighbourhood influences in multilevel models. J Epidemiol Community Health 2011; 65: 688-95.
27. Merlo J, Chaix B, Yang M et al. A brief conceptual tutorial on multilevel analysis in social epidemiology: interpreting neighbourhood differences and the effect of neighbourhood characteristics on individual health. J Epidemiol Community Health 2005; 59: 1022-8.
28. Dalemo S, Hjerpe P, Ohlsson H et al. Variation in plasma calcium analysis in primary care in Sweden-a multilevel analysis. BMC Fam Pract 2010; 11: 43.
29. Hjerpe P, Ohlsson H, Lindblad U et al. Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database. Eur J Clin Pharmacol 2011; 67: 415-23.
30. Chaix B, Merlo J, Chauvin P. Comparison of a spatial approach with the multilevel approach for investigating place effects on health: the example of healthcare utilisation in France. J Epidemiol Community Health 2005; 59: 517-26.
31. Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003; 51: 963-70.
32. Hay AD, Thomas M, Montgomery A et al. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. J Antimicrob Chemother 2005; 56: 146-53.
33. Manges AR, Tabor H, Tellis P et al. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008; 14: 1575-83.
34. Colgan R, Johnson JR, Kuskowski M et al. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008; 52: 846-51.
35. Colodner R, Kometiani I, Chazan B et al. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 2008; 36: 41-5.